Developer docs
API playgroundTry for free, no card

Search company profiles

Singapore Paincare

Full company profile

uuid003e4f9

Namestring
Singapore Paincare
Legal namestring
Singapore Paincare Medical Group
Company typeenum
Public
Founded yearint
2020
Descriptiontext

Singapore Paincare Holdings is a Singapore-based, publicly-listed medical services group (SGX: FRQ) that operates a network of specialist pain clinics focused on diagnosing and treating chronic and acute pain conditions. The Group's flagship Singapore Paincare Center operates from Paragon Medical Centre and Mount Elizabeth Novena Specialist Centre, treating more than 40 pain conditions across musculoskeletal, neurological, cancer, gynaecological and general categories. Services are delivered through direct-to-consumer channels (website pain questionnaire, hotline, walk-ins) and supplemented by doctor referrals and structured insurance partnerships with Income, Great Eastern, MHC, IHP, Prudential, Singlife, Fullerton Health and Adept Health.

The clinical differentiator is the proprietary Painostic® system, developed by founder and Consultant Pain Specialist Dr. Bernard Lee Mun Kam (over 20 years of clinical practice). Painostic® is a proprietary diagnostic and treatment methodology that assesses medical history, posture, and pain-pattern analysis to identify pain sources beyond standard scans, producing personalized minimally invasive treatment plans. The proprietary portfolio includes two named treatment protocols, MYOSPAN and NEUROSPAN, registered under the Painostic® brand. Adjacent ecosystem entities include Singapore Paincare Academy (training), Singapore Paincare TCM (Traditional Chinese Medicine), PTL Spine & Ortho, MSMC Clinic, CSS Screening & Surgery, and Drplus, positioning the Group as a multi-modality specialist platform.

The business model is fee-for-service specialist medical care (consultations and minimally invasive procedures) reimbursed through a mix of patient out-of-pocket payments and partner-insurer direct billing. The Group has 101–250 employees. Capital-markets activity in late 2025 is a material risk factor: a privatization bid by Advance Bridge Healthcare at S$0.16 per share failed to meet scheme conditions by the November 27, 2025 deadline due to funding shortfalls, share trading resumed December 8, 2025, and the company's last traded price remained below its 2020 IPO price of S$0.22.

Short descriptiontext

Singapore Paincare Holdings is a Singapore-based, publicly-listed specialist medical group that diagnoses and treats chronic and acute pain via clinic locations at Paragon Medical Centre and Mount Elizabeth Novena Specialist Centre, using its proprietary Painostic® methodology developed by founder Dr. Bernard Lee Mun Kam.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersSingapore, Singapore
HQ citystring
Singapore
HQ countrystring
Singapore
HQ regionstring
Asia
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
chronic pain treatment, pain management services, interventional pain procedures, specialist medical clinics, minimally invasive treatments
Industry4 codes
1Pain Management Clinics (Interventional & Medical)
CodeHLAFABAHPrimaryYes
2Pain Medicine (Interventional/Neuropathic Pain)
CodeHLAKAIAMPrimaryNo
3Pain Management (Spine & Musculoskeletal)
CodeHLAKALAMPrimaryNo
4Pain Management & Interventional Procedure Centers
CodeHLAFAIAHPrimaryNo
NAICS code2 codes
  • Offices of Physicians62111
  • Freestanding Ambulatory Surgical and Emergency Centers621493
SIC code1 code
  • Services-Offices & Clinics Of Doctors Of Medicine8011
Product category
Pain Management Services
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Medical Consultations and Treatments
TypeProfessional Services
Description

Revenue generated from specialist pain consultations, diagnostic assessments using the Painostic® system, and minimally invasive pain treatment procedures at their clinic locations.

sgpaincare.com
2Insurance Reimbursements
TypeSubscription Recurring
Description

Revenue from partnerships with major insurance providers including Income, Great Eastern, MHC, IHP, Prudential, Singlife, Fullerton, and Adept Health, which provide coverage for specific doctors and treatments.

sgpaincare.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Operations, Marketing or Sales, Technology or R&D
GTM typeB2C
B2C
Offering typeServices
Services
Brand1 record
1Painostic®
Description

Proprietary pain assessment system developed by Singapore Paincare that uncovers the true source of pain by looking beyond scans to assess medical history, posture and pain patterns.

sgpaincare.com
Core offering1 text field

Singapore Paincare delivers specialist medical consultations, diagnostic assessments using its proprietary Painostic® methodology, and minimally invasive interventional pain treatments for chronic and acute pain conditions. Services are provided through flagship clinics at Paragon Medical Centre and Mount Elizabeth Novena Specialist Centre, covering over 40 pain conditions across neck/back, foot, shoulder, knee, head, hand/arm, abdomen/pelvis, genital, cancer, and generalized pain categories.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • Minimally invasive treatment options for faster recovery and minimal downtime
Product overview1 text field

Singapore Paincare is a medical group operating as a unified healthcare platform with its flagship clinic (Singapore Paincare Center) and proprietary pain assessment/treatment system (Painostic®). The portfolio includes specialized pain management clinics, proprietary treatment products (Myospan, Neurospan), and affiliated medical services brands (DrPlus, TCM, PTL Spine, CSS, MSMC) operating across multiple specialist centers in Singapore. The company provides minimally invasive pain treatments through a network of consultant pain specialists.

Product and service1 record
1Singapore Paincare Center
Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership22 partners
Strategic tierCoreTypeOthers
Description

Insurance partner providing health coverage for Singapore Paincare treatments. Coverage applies to specific doctors.

Strategic tierCoreTypeOthers
Description

Insurance partner providing health coverage for Singapore Paincare treatments. Coverage applies to specific doctors.

Strategic tierSupportingTypeOthers
Description

Insurance partner providing health coverage for Singapore Paincare treatments.

Strategic tierSupportingTypeOthers
Description

Insurance partner providing health coverage for Singapore Paincare treatments.

Strategic tierCoreTypeOthers
Description

Insurance partner providing health coverage for Singapore Paincare treatments. Coverage applies to specific doctors.

Strategic tierSupportingTypeOthers
Description

Insurance partner providing health coverage for Singapore Paincare treatments.

Strategic tierSupportingTypeOthers
Description

Insurance partner providing health coverage for Singapore Paincare treatments.

Strategic tierSupportingTypeOthers
Description

Insurance partner providing health coverage for Singapore Paincare treatments.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Partner company listed in the Our Partners section of Singapore Paincare website.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Partner company listed in the Our Partners section of Singapore Paincare website.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Partner company listed in the Our Partners section of Singapore Paincare website.

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Partner company listed in the Our Partners section of Singapore Paincare website.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Partner company listed in the Our Partners section of Singapore Paincare website.

14Uniscaffold Pte Ltd
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Partner company listed in the Our Partners section of Singapore Paincare website.

sgpaincare.com
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Partner company listed in the Our Partners section of Singapore Paincare website.

16S11
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Partner company listed in the Our Partners section of Singapore Paincare website.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Partner company listed in the Our Partners section of Singapore Paincare website.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Related medical company under the group of companies, shown in footer as partner/affiliate.

19Singapore Paincare TCM
Strategic tierSupportingTypeStrategic or Co-development Partner
Description

Traditional Chinese Medicine arm of the group, offering integrated pain management services.

sgpaincare.com
20PTL Spine & Ortho
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Related medical company under the group of companies, shown in footer as partner/affiliate.

sgpaincare.com
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Related medical company under the group of companies, shown in footer as partner/affiliate.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Related medical company under the group of companies, shown in footer as partner/affiliate.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeRegional player
Description

Malaysia-listed healthcare group operating specialist hospitals and fertility services. Comparable as a regional, publicly listed specialist healthcare platform with a similar clinic-and-specialist model.

TypeDirect peer
Description

Singapore-listed specialist healthcare group running a clinic network across Singapore. Comparable as a small-cap SGX-listed clinic-roll-up model in specialist services.

TypeBroad incumbent
Description

One of the largest healthcare operators in Asia, headquartered in Malaysia with Singapore-listed exposure (via Mount Elizabeth, under which Singapore Paincare also leases space). Comparable as a broader incumbent that also competes for premium Singapore specialist volumes.

TypeDirect peer
Description

Singapore-based chain of medical clinics and specialist centers offering family medicine and specialist consultations. Comparable as a Singapore-clinic-chain competitor targeting insured and self-pay patients.

TypeBroad incumbent
Description

Thailand-listed hospital operator and one of Asia's largest private healthcare networks. Comparable as a regional incumbent private healthcare group that competes for medical-travel and specialty volumes.

TypeDirect peer
Description

Singapore-based specialist pain management practice. Directly competes with Singapore Paincare for the same chronic-pain patient segment in the same Singapore market.

TypeDirect peer
Description

Singapore-listed specialist medical services provider focused on oncology and physician-led specialty care. Comparable as a small-cap SGX-listed specialist clinic operator reliant on senior consultants.

TypeRegional player
Description

Indonesia-listed private hospital group with a broad specialist footprint. Comparable as a regional publicly listed private specialist healthcare operator across Southeast Asia.

TypeDirect peer
Description

Singapore-listed specialty medical services group with a similar small-cap, multi-clinic, specialist-consultant model. Closest direct structural comparable on the SGX.

TypeDirect peer
Description

Singapore-listed multi-specialty medical group operating clinics and specialist centers. Highly comparable as a homegrown Singapore specialist healthcare operator with a similar public-company profile and Singapore-only footprint.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries3 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Singapore Paincare

Pain Management Servicessgpaincareholdings.com

Singapore Paincare Holdings is a Singapore-based, publicly-listed specialist medical group that diagnoses and treats chronic and acute pain via clinic locations at Paragon Medical Centre and Mount Elizabeth Novena Specialist Centre, using its proprietary Painostic® methodology developed by founder Dr. Bernard Lee Mun Kam.

What Singapore Paincare does

Singapore Paincare Holdings is a Singapore-based, publicly-listed medical services group (SGX: FRQ) that operates a network of specialist pain clinics focused on diagnosing and treating chronic and acute pain conditions. The Group's flagship Singapore Paincare Center operates from Paragon Medical Centre and Mount Elizabeth Novena Specialist Centre, treating more than 40 pain conditions across musculoskeletal, neurological, cancer, gynaecological and general categories. Services are delivered through direct-to-consumer channels (website pain questionnaire, hotline, walk-ins) and supplemented by doctor referrals and structured insurance partnerships with Income, Great Eastern, MHC, IHP, Prudential, Singlife, Fullerton Health and Adept Health.

The clinical differentiator is the proprietary Painostic® system, developed by founder and Consultant Pain Specialist Dr. Bernard Lee Mun Kam (over 20 years of clinical practice). Painostic® is a proprietary diagnostic and treatment methodology that assesses medical history, posture, and pain-pattern analysis to identify pain sources beyond standard scans, producing personalized minimally invasive treatment plans. The proprietary portfolio includes two named treatment protocols, MYOSPAN and NEUROSPAN, registered under the Painostic® brand. Adjacent ecosystem entities include Singapore Paincare Academy (training), Singapore Paincare TCM (Traditional Chinese Medicine), PTL Spine & Ortho, MSMC Clinic, CSS Screening & Surgery, and Drplus, positioning the Group as a multi-modality specialist platform.

The business model is fee-for-service specialist medical care (consultations and minimally invasive procedures) reimbursed through a mix of patient out-of-pocket payments and partner-insurer direct billing. The Group has 101–250 employees. Capital-markets activity in late 2025 is a material risk factor: a privatization bid by Advance Bridge Healthcare at S$0.16 per share failed to meet scheme conditions by the November 27, 2025 deadline due to funding shortfalls, share trading resumed December 8, 2025, and the company's last traded price remained below its 2020 IPO price of S$0.22.

Singapore Paincare firmographics

Firmographics
Name
Singapore Paincare
Legal name
Singapore Paincare Medical Group
Website
https://sgpaincareholdings.com
Company type
Public
Founded year
2020
Operating status
Operating
Headcount range
101–250 employees
Short description
Singapore Paincare Holdings is a Singapore-based, publicly-listed specialist medical group that diagnoses and treats chronic and acute pain via clinic locations at Paragon Medical Centre and Mount Elizabeth Novena Specialist Centre, using its proprietary Painostic® methodology developed by founder Dr. Bernard Lee Mun Kam.
Ownership category
akta.pro rank

Singapore Paincare industry classification

Industry
Product category
Pain Management Services
NAICS
Offices of Physicians (62111), Freestanding Ambulatory Surgical and Emergency Centers (621493)
SIC
Services-Offices & Clinics Of Doctors Of Medicine (8011)
akta.pro primary industry
Pain Management Clinics (Interventional & Medical) (HLAFABAH)
akta.pro secondary industries
Pain Medicine (Interventional/Neuropathic Pain) (HLAKAIAM), Pain Management (Spine & Musculoskeletal) (HLAKALAM), Pain Management & Interventional Procedure Centers (HLAFAIAH)

Keywords

  • Chronic pain treatment
  • Pain management services
  • Interventional pain procedures
  • Specialist medical clinics
  • Minimally invasive treatments

Where Singapore Paincare is headquartered

Location

Headquarters

HQ city
Singapore
HQ country
Singapore
HQ region
Asia

Offices2 records

Markets served

Singapore Paincare business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D

Revenue model

  1. Medical Consultations and Treatments: Revenue generated from specialist pain consultations, diagnostic assessments using the Painostic® system, and minimally invasive pain treatment procedures at their clinic locations.
  2. Insurance Reimbursements: Revenue from partnerships with major insurance providers including Income, Great Eastern, MHC, IHP, Prudential, Singlife, Fullerton, and Adept Health, which provide coverage for specific doctors and treatments.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Singapore Paincare product offering

Product offering

Core offering

Singapore Paincare delivers specialist medical consultations, diagnostic assessments using its proprietary Painostic® methodology, and minimally invasive interventional pain treatments for chronic and acute pain conditions. Services are provided through flagship clinics at Paragon Medical Centre and Mount Elizabeth Novena Specialist Centre, covering over 40 pain conditions across neck/back, foot, shoulder, knee, head, hand/arm, abdomen/pelvis, genital, cancer, and generalized pain categories.

Product overview

Singapore Paincare is a medical group operating as a unified healthcare platform with its flagship clinic (Singapore Paincare Center) and proprietary pain assessment/treatment system (Painostic®). The portfolio includes specialized pain management clinics, proprietary treatment products (Myospan, Neurospan), and affiliated medical services brands (DrPlus, TCM, PTL Spine, CSS, MSMC) operating across multiple specialist centers in Singapore. The company provides minimally invasive pain treatments through a network of consultant pain specialists.

Differentiator

Problem solved

Functional benefit

Brands

  • Painostic®: Proprietary pain assessment system developed by Singapore Paincare that uncovers the true source of pain by looking beyond scans to assess medical history, posture and pain patterns.

Products and services

  • Singapore Paincare Center

Quantifiable outcome

  • Minimally invasive treatment options for faster recovery and minimal downtime

Companies that use Singapore Paincare

Customer profile

Named customers1 record

Segments2 records

Ideal customer profiles1 record

Singapore Paincare technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Singapore Paincare partnerships and signals

Strategic signal

Partnerships

22 partnerships are on record, tiered core, supporting and minor.

  • Income (NTUC Income)coreOthersInsurance partner providing health coverage for Singapore Paincare treatments. Coverage applies to specific doctors.
  • Great EasterncoreOthersInsurance partner providing health coverage for Singapore Paincare treatments. Coverage applies to specific doctors.
  • MHC (Managed HealthCare)supportingOthersInsurance partner providing health coverage for Singapore Paincare treatments.
  • IHPsupportingOthersInsurance partner providing health coverage for Singapore Paincare treatments.
  • PrudentialcoreOthersInsurance partner providing health coverage for Singapore Paincare treatments. Coverage applies to specific doctors.
  • SinglifesupportingOthersInsurance partner providing health coverage for Singapore Paincare treatments.
  • Fullerton HealthsupportingOthersInsurance partner providing health coverage for Singapore Paincare treatments.
  • Adept HealthsupportingOthersInsurance partner providing health coverage for Singapore Paincare treatments.
  • KT&T Group of CompaniesminorStrategic or Co-development PartnerPartner company listed in the Our Partners section of Singapore Paincare website.
  • InternominorStrategic or Co-development PartnerPartner company listed in the Our Partners section of Singapore Paincare website.
  • CS CeramicheminorStrategic or Co-development PartnerPartner company listed in the Our Partners section of Singapore Paincare website.
  • ATMS (Asian Travel Medical Services)minorChannel Partner/ Reseller/ DistributorPartner company listed in the Our Partners section of Singapore Paincare website.
  • ZublinminorStrategic or Co-development PartnerPartner company listed in the Our Partners section of Singapore Paincare website.
  • Uniscaffold Pte LtdminorStrategic or Co-development PartnerPartner company listed in the Our Partners section of Singapore Paincare website.
  • ShengYi DevelopmentminorStrategic or Co-development PartnerPartner company listed in the Our Partners section of Singapore Paincare website.
  • S11minorStrategic or Co-development PartnerPartner company listed in the Our Partners section of Singapore Paincare website.
  • Hovi-CareminorStrategic or Co-development PartnerPartner company listed in the Our Partners section of Singapore Paincare website.
  • DrplusminorStrategic or Co-development PartnerRelated medical company under the group of companies, shown in footer as partner/affiliate.
  • Singapore Paincare TCMsupportingStrategic or Co-development PartnerTraditional Chinese Medicine arm of the group, offering integrated pain management services.
  • PTL Spine & OrthominorStrategic or Co-development PartnerRelated medical company under the group of companies, shown in footer as partner/affiliate.
  • CSS (Screening & Surgery)minorStrategic or Co-development PartnerRelated medical company under the group of companies, shown in footer as partner/affiliate.
  • MSMC ClinicminorStrategic or Co-development PartnerRelated medical company under the group of companies, shown in footer as partner/affiliate.

Scale indicators3 records

Recent moves7 records

Expansion highlights4 records

Singapore Paincare competitors and assessment

Company assessment

Regional players

  • TMC Life Sciences Berhad: Malaysia-listed healthcare group operating specialist hospitals and fertility services. Comparable as a regional, publicly listed specialist healthcare platform with a similar clinic-and-specialist model.
  • Siloam International Hospitals: Indonesia-listed private hospital group with a broad specialist footprint. Comparable as a regional publicly listed private specialist healthcare operator across Southeast Asia.

Direct peers

  • Q&M Dental Group: Singapore-listed specialist healthcare group running a clinic network across Singapore. Comparable as a small-cap SGX-listed clinic-roll-up model in specialist services.
  • Healthway Medical Group: Singapore-based chain of medical clinics and specialist centers offering family medicine and specialist consultations. Comparable as a Singapore-clinic-chain competitor targeting insured and self-pay patients.
  • The Pain Clinic: Singapore-based specialist pain management practice. Directly competes with Singapore Paincare for the same chronic-pain patient segment in the same Singapore market.
  • TalkMed Group: Singapore-listed specialist medical services provider focused on oncology and physician-led specialty care. Comparable as a small-cap SGX-listed specialist clinic operator reliant on senior consultants.
  • Asian Healthcare Specialists: Singapore-listed specialty medical services group with a similar small-cap, multi-clinic, specialist-consultant model. Closest direct structural comparable on the SGX.
  • Raffles Medical Group: Singapore-listed multi-specialty medical group operating clinics and specialist centers. Highly comparable as a homegrown Singapore specialist healthcare operator with a similar public-company profile and Singapore-only footprint.

Broad incumbents

  • IHH Healthcare Berhad: One of the largest healthcare operators in Asia, headquartered in Malaysia with Singapore-listed exposure (via Mount Elizabeth, under which Singapore Paincare also leases space). Comparable as a broader incumbent that also competes for premium Singapore specialist volumes.
  • Bangkok Dusit Medical Services (BDMS): Thailand-listed hospital operator and one of Asia's largest private healthcare networks. Comparable as a regional incumbent private healthcare group that competes for medical-travel and specialty volumes.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

Singapore Paincare social profiles

Digital presence

Singapore Paincare financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Singapore Paincare leadership team

Management profile

Number of profiles

Profiles1 record

Singapore Paincare subsidiaries and ownership

Company hierarchy

Subsidiaries3 records

Singapore Paincare funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Singapore Paincare M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Singapore Paincare

What does Singapore Paincare do?

Singapore Paincare delivers specialist medical consultations, diagnostic assessments using its proprietary Painostic® methodology, and minimally invasive interventional pain treatments for chronic and acute pain conditions. Services are provided through flagship clinics at Paragon Medical Centre and Mount Elizabeth Novena Specialist Centre, covering over 40 pain conditions across neck/back, foot, shoulder, knee, head, hand/arm, abdomen/pelvis, genital, cancer, and generalized pain categories.

Is Singapore Paincare a public or private company?

Singapore Paincare is a public company. It is classified as public and is currently operating.

When was Singapore Paincare founded?

Singapore Paincare was founded in 2020. It employs 101 to 250 people.

Where is Singapore Paincare based?

Singapore Paincare is headquartered in Singapore, Singapore, in the Asia region.

How does Singapore Paincare make money?

Two revenue lines are on record. Medical Consultations and Treatments are the primary driver. The others are insurance Reimbursements.

Who are Singapore Paincare's main competitors?

Regional players on record are TMC Life Sciences Berhad and Siloam International Hospitals. Direct peers are Q&M Dental Group, Healthway Medical Group, The Pain Clinic, TalkMed Group, Asian Healthcare Specialists and Raffles Medical Group. Broad incumbents are IHH Healthcare Berhad and Bangkok Dusit Medical Services (BDMS).

Does Singapore Paincare have an API?

No public API is recorded for Singapore Paincare.

What industry is Singapore Paincare in?

Singapore Paincare's product category is Pain Management Services. Its primary akta.pro industry code is HLAFABAH, Pain Management Clinics (Interventional & Medical), with a secondary code of HLAKAIAM, Pain Medicine (Interventional/Neuropathic Pain). Its NAICS code is 62111 and its SIC code is 8011.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
The Business TimesStocks to watch: Seatrium, CNMC Goldmine, Singapore PaincareSingapore-listed Seatrium announced an agreement with Maersk Offshore Wind's affiliate Phoenix II A/S for payment of US$360 million upon delivery of a wind turbine installation vessel by Feb 28, 2026. CNMC Goldmine's Malaysian unit received an additional income tax and penalty of RM29.6 million (S$9.4 million) from the Inland Revenue Board of Malaysia for assessment years 2019-2024, against which the gold-mining company intends to file an appeal. The Securities Investors Association (Singapore) called on Singapore Paincare's board to provide greater transparency regarding the impact of its collapsed privatization bid on minority shareholders, citing the offeror Advance Bridge Healthcare's lack of available assets and collateral.The Business TimesSias calls on Singapore Paincare to clarify actions after failed privatisation bidThe Securities Investors Association (Singapore) has called on Singapore Paincare to clarify its actions following the collapse of a privatisation bid by Advance Bridge Healthcare. The failed deal, which lapsed due to expired credit facilities and funding issues, has raised concerns among minority shareholders regarding corporate governance and transparency. Sias is seeking details on the board's awareness of financial risks and any potential breaches of takeover codes during the process.The Business TimesStocks to watch: Sembcorp Industries, Singapore Paincare, Rex InternationalSembcorp Industries confirmed it is in talks to acquire Australian utility company Alinta Energy, though no definitive transaction has been entered into and discussions are ongoing. The privatisation offer for Singapore Paincare by Advance Bridge Healthcare has fallen through after the offeror failed to satisfy scheme conditions by the Nov 27 expiry date, with the S$0.16 per share offer representing a 27% premium over the last traded price but below its 2020 IPO price. Rex International's subsidiary Jasmine Energy has raised US$25 million in senior secured bonds carrying a 14% coupon to fund a three-well drilling campaign in 2026.The Straits TimesSingapore Paincare privatisation bid failsSingapore Paincare, a Catalist-listed company, saw its S$0.16 per share privatization offer from Advance Bridge Healthcare lapse on November 27 after the offeror failed to meet scheme conditions by the deadline due to funding issues. UOB's credit facilities with the offeror expired, leaving Advance Bridge Healthcare unable to secure new financial confirmation to proceed with the deal. Singapore's securities regulator Sias had previously flagged concerns over messages sent by Singapore Paincare's CEO/COO to shareholders urging support for the delisting before the vote.The Business TimesSingapore Paincare privatisation bid fails as offeror fails to meet conditions by deadlineSingapore Paincare's privatisation bid from Advance Bridge Healthcare has failed as the offeror did not meet the scheme of arrangement conditions by the deadline of Nov 27. The offer was made at S$0.16 per share, below the company's IPO price of S$0.22 in 2020, and the failure was compounded by lapses in credit facilities and lack of available assets for funding. Trading of Singapore Paincare shares will resume on Dec 8.